In the rapidly advancing landscape of precision medicine, the promise of personalized health outcomes relies heavily on one critical component: the data. For decades, the human genetics community has grappled with a significant "representation gap," where genomic databases have been overwhelmingly populated by individuals of European ancestry. This bias threatens to exacerbate existing health disparities, as algorithms and therapies developed from these datasets may not be applicable or effective for the global population.
A groundbreaking study published in Human Genetics and Genomics Advances (HGG Advances), titled "Underrepresented Voices in a Colorado Biobank: Perspectives from Focus Groups on Motivations, Return of Results, and Data Sharing," seeks to address these systemic hurdles. Led by researchers Carissa Sherman, PhD, and Betzaida Maldonado from the University of Colorado Anschutz, the project offers a qualitative deep dive into what motivates underrepresented individuals to participate in biobanking—and, perhaps more importantly, what barriers prevent them from doing so.
Main Facts: The Quest for Inclusive Genomic Data
The study centers on the Colorado Center for Personalized Medicine Biobank. By conducting focus groups with diverse community members, the research team sought to move beyond the quantitative metrics of participation to understand the human experience behind the biospecimen.
The core findings suggest that trust, transparency, and personal connection are the primary drivers for participation among underrepresented groups. The researchers found that when potential participants see their own identities reflected in the research team, their willingness to engage increases significantly. The study underscores that "representation" is not merely a box to be checked; it is a foundational requirement for building a biobank that serves the public interest fairly and effectively.
Chronology: From Concept to Clinical Insight
The project was born out of a growing awareness of the limitations inherent in current genomic datasets.
- Initial Phases: Dr. Katrina Claw and Dr. Randi Johnson initiated the project, identifying the need to engage with local populations who were historically absent from the Colorado Biobank.
- Team Assembly: The research team was intentionally curated to include individuals from Indigenous, Hispanic, and queer backgrounds, ensuring that the researchers mirrored the diversity of the communities they sought to study.
- Focus Group Execution: Over several months, the team conducted intensive focus groups. Rather than using traditional, sterile survey methods, the researchers prioritized an environment of "camaraderie and trust."
- Synthesis and Publication: Following the qualitative data collection, the team synthesized the participants’ feedback into a set of actionable recommendations, which were peer-reviewed and published in HGG Advances in late 2026.
Supporting Data: Why Qualitative Matters
While much of modern genetics is defined by quantitative data—large-scale sequencing, variant calling, and statistical association—this study highlights the indispensable value of qualitative research.
The participants in this study did not just provide data; they provided a roadmap for better engagement. One particularly innovative suggestion that emerged from the focus groups was the creation of an interface similar to modern "food delivery apps." Participants expressed a desire for a "biospecimen tracking" system that would allow them to see the journey of their samples—from initial collection to analysis, and finally, to the reporting of results in their health charts. This desire for transparency suggests that the traditional "black box" model of biobanking is increasingly viewed as obsolete by a more informed and empowered public.
Official Responses and Researcher Perspectives
In an interview with HGG Advances, the lead researchers shared their personal motivations and the challenges they faced as early-career scientists.
On Representation and Trust
Dr. Carissa Sherman, who brings her experience as a member of the Diné (Navajo) Tribe to the project, emphasized the importance of cultural humility in research. "Working with individuals from various backgrounds provides greater insight into some of the similar motivators and barriers to participation," she noted. She described how participants often connected with the team because they "could feel the bond of having someone who is like you."
Betzaida Maldonado, a first-generation Latina doctoral student, reflected on the personal resonance of the work. "I noticed the underrepresentation of specific communities in genomics research during the first year of my PhD," she explained. Her goal was to determine how researchers can better engage those who have been traditionally excluded, turning the research process into a two-way street of information and benefit.
Navigating the Challenges of Early-Career Science
Both researchers addressed the hurdles of being young scientists in a demanding field. Dr. Sherman discussed the challenge of navigating academic expectations that prioritize rapid, loud responses over the reflective, listening-based approach common in her culture. "I’ve become more comfortable navigating times to speak up and times to listen," she shared, crediting her mentor, Dr. Claw, for pushing her to step outside her comfort zone.
Maldonado highlighted the struggle of balancing a multitude of research interests. "As young scientists, we are eager to learn everything," she noted. "The challenge is to identify the area of research that most aligns with our interests and career goals."
Implications: A New Era for Genomic Equity
The implications of this work are broad, touching on everything from clinical practice to the ethics of data sovereignty.
Empowering the Citizen-Participant
Dr. Sherman argues that the ultimate goal is to empower participants. "I hope citizens continue to advocate for themselves and others in biomedical/genetic settings," she stated. The study suggests that if participants are treated as partners rather than subjects, the quality and scope of data collection will naturally improve.
The Rise of Tribal and Data Sovereignty
In a broader look at the state of the field, Dr. Sherman pointed to the establishment of the first federally funded Tribal data repository—"The Data for Indigenous Implementations, Interventions, and Innovations Tribal Data Repository"—as a milestone for the future. This represents a significant shift toward Indigenous data sovereignty, where populations maintain control over how their genomic information is stored and used.
The Interdisciplinary Future
Maldonado pointed toward the interdisciplinary future of the field, noting the fascinating ways that disparate sciences are converging. She cited recent advancements in recovering nuclear DNA from rootless hairs—a feat that bridges the gap between anthropology, ancient DNA studies, and computational biology. This kind of cross-pollination, she believes, is the future of solving complex problems in human genetics.
Policy and Practice Recommendations
The study concludes with a call to action for the scientific community:
- Prioritize Diverse Teams: Recruitment and retention of diverse researchers are not just HR goals; they are scientific necessities for building trust with diverse participant populations.
- Adopt Mixed-Methods Research: Qualitative research must be elevated to the same status as quantitative studies to capture the "why" behind participant behavior.
- Invest in Transparency: Systems like the suggested "biospecimen tracker" should be prioritized to provide participants with clear insights into how their contributions are being utilized.
- Community-Centric Design: Research projects should be piloted in close consultation with the target communities to identify potential barriers before they become systemic failures.
As the scientific community looks toward the next decade of genomic discovery, the work of researchers like Sherman and Maldonado serves as a vital reminder: the most sophisticated technology in the world is useless if it is not grounded in the trust and participation of the people it intends to serve. By listening to underrepresented voices today, the genetics community is laying the groundwork for a more equitable, inclusive, and effective future for precision medicine.
About the Author
